ARS Pharmaceuticals Appoints New CEO

ARS Pharmaceuticals has appointed Donn Casale as its new chief executive officer effective July 7, 2026, succeeding co-founder Richard Lowenthal. Lowenthal will step down from his role on the same day.

By Khushi Singh, SA News Editor · Seeking Alpha · July 7, 2026, 20:35 UTC

ARS Pharmaceuticals Appoints New CEO

Tickers: $SPRY

Topics: CEO appointment Leadership change

Read the full article at Seeking Alpha

More World news

Rival Technologies Index Reveals Gen Z Financial Constraints Amidst Optimistic Outlook PR Newswire · November 12, 2026, 13:42 UTC
Canadian Cybersecurity Job Postings Rise While Entry-Level Opportunities Decline PR Newswire · November 12, 2026, 13:42 UTC
Klarna Appoints Robinhood's Chris Koegel as Chief Financial Officer Seeking Alpha · November 12, 2026, 13:35 UTC
Kyverna Therapeutics Reports Q3 GAAP EPS of -$0.68, Slightly Beating Estimates Seeking Alpha · November 12, 2026, 13:37 UTC
TelyRx Holdings Appoints Co-Founder Benjamin Atkins as Interim CEO Seeking Alpha · November 12, 2026, 13:38 UTC
Nvidia shares fall following analyst downgrades and reports of potential CEO leadership changes Seeking Alpha · November 12, 2026, 13:38 UTC
Technosylva Launches Technosylva Planning Application for Multi-Hazard Utility Risk Management PR Newswire · November 12, 2026, 13:38 UTC
PVH Corp. Announces Global Workforce Reduction of Approximately 4% Seeking Alpha · November 12, 2026, 13:34 UTC
Analysis Reveals 75% of Americans Reside in Car-Dependent Areas PR Newswire · November 12, 2026, 13:38 UTC
ASML Positioned for Potential Stock Split Amid Surging AI Demand and Record Results Motley Fool · November 12, 2026, 13:31 UTC